• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
SONG Gaoping,CHEN Wenmin,YU Pengxin,DUAN Lili.Research progress on the anti-tumor mechanism of indirubin and its derivatives[J].Journal Of Pharmaceutical Research,2026,45(2):224-229[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3071times   Download 866次 QR Code for this article
Scan with your phone!
靛玉红及其衍生物的抗肿瘤机制研究进展
宋高平,陈文敏,禹鹏鑫,段莉莉
Font:Larger+|Default|Smaller-
(天津中医药大学中药学院,天津 301617)
摘要:
靛玉红是来源于中药青黛的双吲哚生物碱,对多种癌症均表现出抗癌活性,尤其是对慢性粒细胞白血病。本文从靛玉红的结构修饰入手,并从细胞水平,与癌症相关的蛋白,靶点和通路等方面对靛玉红及其衍生物的抗肿瘤机制进行综述,为具有优秀抗肿瘤活性的新型靛玉红衍生物的研发提供依据。
关键词:  靛玉红  靛玉红衍生物  结构修饰  抗肿瘤
DOI:10.13506/j.cnki.jpr.2026.02.016
基金项目:天津市卫生健康委员会中医中西医结合科研课题项目(No.2023077)
Publication Date:February 25, 2026
Research progress on the anti-tumor mechanism of indirubin and its derivatives
SONG Gaoping,CHEN Wenmin,YU Pengxin,DUAN Lili
(School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China)
Abstract:
Indirubin, a kind of bis-indole alkaloid, is derived from the traditional Chinese medicine Indigofera tinctoria L, and exhibits anti-tumor activities against various cancers, especially chronic myelocytic leukemia. This paper describes the structural modification of Indirubin and relative anti-tumor mechanisms from the cellular level, cancer-related proteins, targets, and signaling pathways, providing a basis for the development of novel Indirubin derivatives with excellent anti-tumor activity.
Key words:  Indirubin  Indirubin derivatives  Structural modification  Anti-tumor
Today's Visits:447    Total Visits:2383131
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.